SPONSOR
Northern Jiangsu People's Hospital
Total Trials
4
Recruiting
4
Phases
Phase 2
Conditions studied: Hepatocellular Carcinoma (HCC)CirrhosisHypersplenismHypertension, PortalCirrhoses, LiverSplenectomy; StatusPartial
Northern Jiangsu People's Hospital is a clinical research sponsor with 4 registered studies on ClinicalTrials.gov, of which 4 are actively recruiting participants. Research covers conditions including Hepatocellular Carcinoma (HCC), Cirrhosis, Hypersplenism, Hypertension, Portal.
The trial portfolio spans Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Northern Jiangsu People's Hospital
How many clinical trials has Northern Jiangsu People's Hospital sponsored?
ClinicalMetric currently tracks 4 clinical trials sponsored by Northern Jiangsu People's Hospital, of which 4 are actively recruiting participants. These trials cover conditions including Hepatocellular Carcinoma (HCC), Cirrhosis, Hypersplenism. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Northern Jiangsu People's Hospital research focus on?
Northern Jiangsu People's Hospital clinical trials span Hepatocellular Carcinoma (HCC), Cirrhosis, Hypersplenism, Hypertension, Portal, Cirrhoses, Liver, and additional conditions. The research pipeline includes Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Northern Jiangsu People's Hospital clinical trial?
To participate in a Northern Jiangsu People's Hospital trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Northern Jiangsu People's Hospital trials with current recruitment status updated daily.
Clinical Trials by Northern Jiangsu People's Hospital
NCT07337460 Phase 2
Recruiting
Efficacy and Safety of Icaritin Combined With mFOLFOX in Postoperative HCC With High-risk Recurrence Factors
Hepatocellular Carcinoma (HCC)
NCT07462091
Recruiting
Vagus Nerve-guided Laparoscopic Splenectomy and Azygoportal Disconnection
Cirrhosis
NCT07337421 Phase 2
Recruiting
Efcacy and Safety of Postoperative Adjuvant Hepatic Arterial Infusion Chemotherapy With mFOLFOX in Hepatocellular Carcinoma With High-risk Recurrence Factors
Hepatocellular Carcinoma (HCC)
NCT07205471
Recruiting
Laparoscopic Partial Splenectomy for Hypersplenism in Liver Cirrhosis Patients
Cirrhoses, Liver
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology